Role of the p16 tumor suppressor gene in cancer.

Abstract

Since its discovery as a CDKI (cyclin-dependent kinase inhibitor) in 1993, the tumor suppressor p16 (INK4A/MTS-1/CDKN2A) has gained widespread importance in cancer. The frequent mutations and deletions of p16 in human cancer cell lines first suggested an important role for p16 in carcinogenesis. This genetic evidence for a causal role was significantly… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.